Study effectiveness of tamsulosin in the management of lower third ureteral stones with size 1cm or less
Abstract
Background: Ureteral stones are a common problem in daily emergency department practice, and medical therapy may be offered to facilitate stone expulsion in patients with distal ureteral calculi.
Aim: The purpose of this study was to evaluate the effectiveness of tamsulosin in management of lower ureteric stones with size 1 cm or less.
Materials and Methods: This was an analytical comparative study (prospective) included 142 patients with stones in the lower third of ureter at Tishreen University Hospital- Lattakia-Syria during one year period (2023- 2024). Patients were divided into two groups according to the method of management: group 1 included 71 patients who received treatment with tamsulosin and group 2 included 71 patients who didn't receive any therapy, in which final outcome were compared between two groups.
Results: A total of 142 patients, 101 males (71.1%) and 41 females (28.9%) with a mean age of 37.66±14.6 years were included in the study. The stones were solitary in in 95.8%, multiple in 4.2% with stone sizes less than 5 mm in 63 cases(44.4%). There were no significant differences between two groups regarding of age(p:0.6), sex(p:0.3), number of stones(p:0.6), and its size(p:0.2). The success rate of stone expulsion was higher in tamsulosin group but without significant difference(87.3% versus 78.9%,p:.0.09). There were no significant correlation between size of stones and the rate of success in the two groups(p:0.07). In addition to, mean duration of stones passage was significantly shorter in tamsulosin group(7.66±2.4 days versus 10.6±3.3 in placebo,p:0.01).
Conclusion: The current study demonstrated that tamsulosin provides better stone expulsion in the cases of distal ureterolithiasis without significant difference compared with placebo, but with minimum amount of time.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series
Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in Tishreen University Journal for Research and Scientific Studies - Health Sciences Series . The Readers have the right to send, print and subscribe to the initial version of the article, and the title of Tishreen University Journal for Research and Scientific Studies - Health Sciences Series Publisher
journal uses a CC BY-NC-SA license which mean
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
- The licensor cannot revoke these freedoms as long as you follow the license terms.
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- NonCommercial — You may not use the material for commercial purposes.
- ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
